Skip to main content
Top
Published in: BMC Gastroenterology 1/2024

Open Access 01-12-2024 | Rectal Cancer | Research

Development and validation of comprehensive nomograms from the SEER database for predicting early mortality in metastatic rectal cancer patients

Authors: Yanli Li, Ting Tao, Yun Liu

Published in: BMC Gastroenterology | Issue 1/2024

Login to get access

Abstract

Background

Metastatic rectal cancer is an incurable malignancy, which is prone to early mortality. We aimed to establish nomograms for predicting the risk of early mortality in patients with metastatic rectal cancer.

Methods

In this study, clinical data were obtained from the Surveillance, Epidemiology, and End Results (SEER) database.We utilized X-tile software to determine the optimal cut-off points of age and tumor size in diagnosis. Significant independent risk factors for all-cause and cancer-specific early mortality were determined by the univariate and multivariate logistic regression analyses, then we construct two practical nomograms. In order to assess the predictive performance of nomograms, we performed calibration plots, time-dependent receiver-operating characteristic curve (ROC), decision curve analysis (DCA) and clinical impact curve (CIC).

Results

A total of 2570 metastatic rectal cancer patients were included in the study. Multivariate logistic regression analyses revealed that age at diagnosis, CEA level, tumor size, surgical intervention, chemotherapy, radiotherapy, and metastases to bone, brain, liver, and lung were independently associated with early mortality of metastatic rectal cancer patients in the training cohort. The area under the curve (AUC) values of nomograms for all-cause and cancer-specific early mortality were all higher than 0.700. Calibration curves indicated that the nomograms accurately predicted early mortality and exhibited excellent discrimination. DCA and CIC showed moderately positive net benefits.

Conclusions

This study successfully generated applicable nomograms that predicted the high-risk early mortality of metastatic rectal cancer patients, which can assist clinicians in tailoring more effective treatment regimens.
Literature
1.
go back to reference São Julião GP, Habr-Gama A, Vailati BB, Araujo SEA, Fernandez LM, Perez RO. New strategies in rectal Cancer. Surg Clin North Am. 2017;97(3):587–604.CrossRefPubMed São Julião GP, Habr-Gama A, Vailati BB, Araujo SEA, Fernandez LM, Perez RO. New strategies in rectal Cancer. Surg Clin North Am. 2017;97(3):587–604.CrossRefPubMed
2.
go back to reference Zhong X, Wang L, Shao L, Zhang X, Hong L, Chen G, Wu J. Prognostic nomogram for rectal Cancer patients with Tumor deposits. Front Oncol. 2022;12:808557.CrossRefPubMedPubMedCentral Zhong X, Wang L, Shao L, Zhang X, Hong L, Chen G, Wu J. Prognostic nomogram for rectal Cancer patients with Tumor deposits. Front Oncol. 2022;12:808557.CrossRefPubMedPubMedCentral
3.
go back to reference Tan WJ, Tan HJ, Dorajoo SR, Foo FJ, Tang CL, Chew MH. Rectal Cancer surveillance-recurrence patterns and survival outcomes from a Cohort followed up beyond 10 years. J Gastrointest cancer. 2018;49(4):422–8.CrossRefPubMed Tan WJ, Tan HJ, Dorajoo SR, Foo FJ, Tang CL, Chew MH. Rectal Cancer surveillance-recurrence patterns and survival outcomes from a Cohort followed up beyond 10 years. J Gastrointest cancer. 2018;49(4):422–8.CrossRefPubMed
4.
go back to reference Wang G, Zheng Z, Chen J, Ye J, Tang Z, Fang Y, Yao K, Zeng Q, Yang Y, Tang H, et al. A nomogram for predicting good response after neoadjuvant chemoradiotherapy for locally advanced rectal cancer: a retrospective, double-center, cohort study. Int J Colorectal Dis. 2022;37(10):2157–66.CrossRefPubMedPubMedCentral Wang G, Zheng Z, Chen J, Ye J, Tang Z, Fang Y, Yao K, Zeng Q, Yang Y, Tang H, et al. A nomogram for predicting good response after neoadjuvant chemoradiotherapy for locally advanced rectal cancer: a retrospective, double-center, cohort study. Int J Colorectal Dis. 2022;37(10):2157–66.CrossRefPubMedPubMedCentral
5.
go back to reference Kim JY, Kim JS, Baek MJ, Kim CN, Choi WJ, Park DK, Namgung H, Lee SC, Lee SJ. Prospective multicenter phase II clinical trial of FOLFIRI chemotherapy as a neoadjuvant treatment for colorectal cancer with multiple liver metastases. J Korean Surg Soc. 2013;85(4):154–60.CrossRefPubMedPubMedCentral Kim JY, Kim JS, Baek MJ, Kim CN, Choi WJ, Park DK, Namgung H, Lee SC, Lee SJ. Prospective multicenter phase II clinical trial of FOLFIRI chemotherapy as a neoadjuvant treatment for colorectal cancer with multiple liver metastases. J Korean Surg Soc. 2013;85(4):154–60.CrossRefPubMedPubMedCentral
6.
go back to reference Dekker E, Tanis PJ, Vleugels JLA, Kasi PM, Wallace MB. Colorectal cancer. Lancet (London England). 2019;394(10207):1467–80.CrossRefPubMed Dekker E, Tanis PJ, Vleugels JLA, Kasi PM, Wallace MB. Colorectal cancer. Lancet (London England). 2019;394(10207):1467–80.CrossRefPubMed
7.
go back to reference Luo D, Liu Q, Yu W, Ma Y, Zhu J, Lian P, Cai S, Li Q, Li X. Prognostic value of distant metastasis sites and surgery in stage IV colorectal cancer: a population-based study. Int J Colorectal Dis. 2018;33(9):1241–9.CrossRefPubMed Luo D, Liu Q, Yu W, Ma Y, Zhu J, Lian P, Cai S, Li Q, Li X. Prognostic value of distant metastasis sites and surgery in stage IV colorectal cancer: a population-based study. Int J Colorectal Dis. 2018;33(9):1241–9.CrossRefPubMed
8.
go back to reference Zhao B, Wang J, Ma Z, Ye H, Yang T, Meng K. Development and validation of a prognostic nomogram for rectal cancer patients who underwent surgical resection. Pathol Oncol Research: POR. 2023;29:1611014.CrossRefPubMedPubMedCentral Zhao B, Wang J, Ma Z, Ye H, Yang T, Meng K. Development and validation of a prognostic nomogram for rectal cancer patients who underwent surgical resection. Pathol Oncol Research: POR. 2023;29:1611014.CrossRefPubMedPubMedCentral
9.
go back to reference Han L, Dai W, Mo S, Xiang W, Li Q, Xu Y, Cai G, Wang R. Nomogram of conditional survival probability of long-term survival for metastatic colorectal Cancer: a real-World Data Retrospective Cohort Study from SEER database. Int J Surg (London England). 2021;92:106013.CrossRef Han L, Dai W, Mo S, Xiang W, Li Q, Xu Y, Cai G, Wang R. Nomogram of conditional survival probability of long-term survival for metastatic colorectal Cancer: a real-World Data Retrospective Cohort Study from SEER database. Int J Surg (London England). 2021;92:106013.CrossRef
10.
go back to reference Zhang X, Hu Y, Deng K, Ren W, Zhang J, Liu C, Ma B. Developing prognostic nomograms to predict overall survival and cancer-specific survival in synchronous multiple primary colorectal cancer based on the SEER database. J Cancer Res Clin Oncol. 2023;149(15):14057–70.CrossRefPubMed Zhang X, Hu Y, Deng K, Ren W, Zhang J, Liu C, Ma B. Developing prognostic nomograms to predict overall survival and cancer-specific survival in synchronous multiple primary colorectal cancer based on the SEER database. J Cancer Res Clin Oncol. 2023;149(15):14057–70.CrossRefPubMed
11.
go back to reference Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global Cancer statistics 2020: GLOBOCAN estimates of incidence and Mortality Worldwide for 36 cancers in 185 countries. Cancer J Clin. 2021;71(3):209–49.CrossRef Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global Cancer statistics 2020: GLOBOCAN estimates of incidence and Mortality Worldwide for 36 cancers in 185 countries. Cancer J Clin. 2021;71(3):209–49.CrossRef
12.
go back to reference Keller DS, Berho M, Perez RO, Wexner SD, Chand M. The multidisciplinary management of rectal cancer. Nat Reviews Gastroenterol Hepatol. 2020;17(7):414–29.CrossRef Keller DS, Berho M, Perez RO, Wexner SD, Chand M. The multidisciplinary management of rectal cancer. Nat Reviews Gastroenterol Hepatol. 2020;17(7):414–29.CrossRef
13.
go back to reference Braun R, Anthuber L, Hirsch D, Wangsa D, Lack J, McNeil NE, Heselmeyer-Haddad K, Torres I, Wangsa D, Brown MA, et al. Single-Cell-Derived Primary Rectal Carcinoma Cell Lines Reflect Intratumor Heterogeneity Associated with Treatment Response. Clin cancer Research: Official J Am Association Cancer Res. 2020;26(13):3468–80.CrossRef Braun R, Anthuber L, Hirsch D, Wangsa D, Lack J, McNeil NE, Heselmeyer-Haddad K, Torres I, Wangsa D, Brown MA, et al. Single-Cell-Derived Primary Rectal Carcinoma Cell Lines Reflect Intratumor Heterogeneity Associated with Treatment Response. Clin cancer Research: Official J Am Association Cancer Res. 2020;26(13):3468–80.CrossRef
14.
go back to reference Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2023. Cancer J Clin. 2023;73(1):17–48.CrossRef Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2023. Cancer J Clin. 2023;73(1):17–48.CrossRef
15.
go back to reference Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Cancer J Clin. 2018;68(6):394–424.CrossRef Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Cancer J Clin. 2018;68(6):394–424.CrossRef
16.
go back to reference Abasse Kassim S, Tang W, Abbas M, Wu S, Meng Q, Zhang C, Li X, Chen R. Clinicopathologic and epidemiological characteristics of prognostic factors in post-surgical survival of colorectal cancer patients in Jiangsu Province, China. Cancer Epidemiol. 2019;62:101565.CrossRefPubMed Abasse Kassim S, Tang W, Abbas M, Wu S, Meng Q, Zhang C, Li X, Chen R. Clinicopathologic and epidemiological characteristics of prognostic factors in post-surgical survival of colorectal cancer patients in Jiangsu Province, China. Cancer Epidemiol. 2019;62:101565.CrossRefPubMed
17.
go back to reference Rönnow CF, Arthursson V, Toth E, Krarup PM, Syk I, Thorlacius H. Lymphovascular infiltration, not depth of Invasion, is the critical risk factor of metastases in early colorectal Cancer: Retrospective Population-based Cohort Study on Prospectively Collected Data, including validation. Ann Surg. 2022;275(1):e148–54.CrossRefPubMed Rönnow CF, Arthursson V, Toth E, Krarup PM, Syk I, Thorlacius H. Lymphovascular infiltration, not depth of Invasion, is the critical risk factor of metastases in early colorectal Cancer: Retrospective Population-based Cohort Study on Prospectively Collected Data, including validation. Ann Surg. 2022;275(1):e148–54.CrossRefPubMed
18.
go back to reference Zhang J, Gong Z, Gong Y, Guo W. Development and validation of nomograms for prediction of overall survival and cancer-specific survival of patients with stage IV colorectal cancer. Jpn J Clin Oncol. 2019;49(5):438–46.CrossRefPubMedPubMedCentral Zhang J, Gong Z, Gong Y, Guo W. Development and validation of nomograms for prediction of overall survival and cancer-specific survival of patients with stage IV colorectal cancer. Jpn J Clin Oncol. 2019;49(5):438–46.CrossRefPubMedPubMedCentral
19.
go back to reference Wang X, Mao M, Xu G, Lin F, Sun P, Baklaushev VP, Chekhonin VP, Peltzer K, Zhang J, Zhang C. The incidence, associated factors, and predictive nomogram for early death in stage IV colorectal cancer. Int J Colorectal Dis. 2019;34(7):1189–201.CrossRefPubMed Wang X, Mao M, Xu G, Lin F, Sun P, Baklaushev VP, Chekhonin VP, Peltzer K, Zhang J, Zhang C. The incidence, associated factors, and predictive nomogram for early death in stage IV colorectal cancer. Int J Colorectal Dis. 2019;34(7):1189–201.CrossRefPubMed
20.
go back to reference Ge H, Yan Y, Xie M, Guo L, Tang D. Construction of a nomogram to predict overall survival for patients with M1 stage of colorectal cancer: a retrospective cohort study. Int J Surg (London England). 2019;72:96–101.CrossRef Ge H, Yan Y, Xie M, Guo L, Tang D. Construction of a nomogram to predict overall survival for patients with M1 stage of colorectal cancer: a retrospective cohort study. Int J Surg (London England). 2019;72:96–101.CrossRef
21.
go back to reference Song J, Chen Z, Huang D, Wu Y, Lin Z, Chi P, Xu B. Nomogram Predicting overall survival of Resected locally advanced rectal Cancer patients with Neoadjuvant Chemoradiotherapy. Cancer Manage Res. 2020;12:7375–82.CrossRef Song J, Chen Z, Huang D, Wu Y, Lin Z, Chi P, Xu B. Nomogram Predicting overall survival of Resected locally advanced rectal Cancer patients with Neoadjuvant Chemoradiotherapy. Cancer Manage Res. 2020;12:7375–82.CrossRef
22.
go back to reference Girard P, Ducreux M, Baldeyrou P, Rougier P, Le Chevalier T, Bougaran J, Lasser P, Gayet B, Ruffié P, Grunenwald D. Surgery for lung metastases from colorectal cancer: analysis of prognostic factors. J Clin Oncology: Official J Am Soc Clin Oncol. 1996;14(7):2047–53.CrossRef Girard P, Ducreux M, Baldeyrou P, Rougier P, Le Chevalier T, Bougaran J, Lasser P, Gayet B, Ruffié P, Grunenwald D. Surgery for lung metastases from colorectal cancer: analysis of prognostic factors. J Clin Oncology: Official J Am Soc Clin Oncol. 1996;14(7):2047–53.CrossRef
23.
go back to reference Pfannschmidt J, Dienemann H, Hoffmann H. Surgical resection of pulmonary metastases from colorectal cancer: a systematic review of published series. Ann Thorac Surg. 2007;84(1):324–38.CrossRefPubMed Pfannschmidt J, Dienemann H, Hoffmann H. Surgical resection of pulmonary metastases from colorectal cancer: a systematic review of published series. Ann Thorac Surg. 2007;84(1):324–38.CrossRefPubMed
Metadata
Title
Development and validation of comprehensive nomograms from the SEER database for predicting early mortality in metastatic rectal cancer patients
Authors
Yanli Li
Ting Tao
Yun Liu
Publication date
01-12-2024
Publisher
BioMed Central
Published in
BMC Gastroenterology / Issue 1/2024
Electronic ISSN: 1471-230X
DOI
https://doi.org/10.1186/s12876-024-03178-y

Other articles of this Issue 1/2024

BMC Gastroenterology 1/2024 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.